Aehr Test Systems - AEHR Stock Forecast, Price & News

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Aehr Test Systems in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" AEHR shares.
View AEHR analyst ratings or view top-rated stocks.

1 Wall Street analysts have issued twelve-month price targets for Aehr Test Systems' shares. Their AEHR share price forecasts range from $45.00 to $45.00. On average, they predict the company's share price to reach $45.00 in the next year. This suggests a possible upside of 18.9% from the stock's current price.
View analysts price targets for AEHR or view top-rated stocks among Wall Street analysts.

Aehr Test Systems' stock was trading at $20.10 on January 1st, 2023. Since then, AEHR stock has increased by 88.3% and is now trading at $37.85.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 30th 2023.
View our AEHR earnings forecast.

Aehr Test Systems will be holding an earnings conference call on Thursday, March 30th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-0088 with passcode "2107882".

Aehr Test Systems (NASDAQ:AEHR) announced its quarterly earnings data on Thursday, January, 5th. The semiconductor company reported $0.13 earnings per share for the quarter, topping analysts' consensus estimates of $0.04 by $0.09. The semiconductor company earned $14.82 million during the quarter, compared to analyst estimates of $12.01 million. Aehr Test Systems had a net margin of 20.23% and a trailing twelve-month return on equity of 26.31%.

ETFs with the largest weight of Aehr Test Systems (NASDAQ:AEHR) stock in their portfolio include Changebridge Select Equity ETF (CBSE), Changebridge Long/Short Equity ETF (CBLS), Invesco DWA Industrials Momentum ETF (PRN), SPDR FactSet Innovative Technology ETF (XITK), Invesco Nasdaq Future Gen 200 ETF (QQQS), Invesco DWA SmallCap Momentum ETF (DWAS), Innovator IBD 50 ETF (FFTY) and Barrons 400 ETF (BFOR).

Aehr Test Systems issued an update on its FY 2023 earnings guidance on Thursday, March, 2nd. The company provided EPS guidance of for the period. The company issued revenue guidance of $60.00 million-$70.00 million, compared to the consensus revenue estimate of $65.17 million.

1 employees have rated Aehr Test Systems Chief Executive Officer Rhea J. Posedel on Glassdoor.com. Rhea J. Posedel has an approval rating of 100% among the company's employees. This puts Rhea J. Posedel in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Aehr Test Systems investors own include Arbutus Biopharma (ABUS), Co-Diagnostics (CODX), iBio (IBIO), Inovio Pharmaceuticals (INO), Palatin Technologies (PTN), Tonix Pharmaceuticals (TNXP), T2 Biosystems (TTOO), Vaxart (VXRT), Aclaris Therapeutics (ACRS) and Acasti Pharma (ACST).

Aehr Test Systems trades on the NASDAQ under the ticker symbol "AEHR."

Aehr Test Systems' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Driehaus Capital Management LLC (3.21%), Point72 Asset Management L.P. (2.60%), Morgan Stanley (1.24%), D L Carlson Investment Group Inc. (1.15%), Sculptor Capital LP (0.00%) and Geode Capital Management LLC (0.88%). Insiders that own company stock include Alistair N Sporck, David Fucci, David S Hendrickson, Donald P Richmond II, Gayn Erickson, Geoffrey Gates Scott, Howard T Slayen, Kenneth B Spink, Kenneth B Spink, Laura Oliphant, Mario M Rosati, Michael A Brannan, Rhea J Posedel and Vernon Rogers.
View institutional ownership trends.

Shares of AEHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AEHR stock can currently be purchased for approximately $37.85.

Aehr Test Systems (NASDAQ:AEHR) has a market capitalization of $1.05 billion and generates $50.83 million in revenue each year. The semiconductor company earns $9.45 million in net income (profit) each year or $0.43 on an earnings per share basis.

Aehr Test Systems' mailing address is 400 KATO TERRACE, FREMONT CA, 94539. The official website for the company is www.aehr.com. The semiconductor company can be reached via phone at (510) 623-9400, via email at aehr@mkr-group.com, or via fax at 510-623-9450.